Ipsum Pharmaceuticals Private Limited
Wholesale trading of pharmaceutical and chemical products for various branches of medicine.
2012 | Hyderabad, Telangana (India) | Active
Ipsum Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.70 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 4.07%
- Profit Growth 9.17%
- Ebitda 1.42%
- Net Worth 9.88%
- Total Assets 36.78%
About Ipsum Pharmaceuticals
Ipsum Pharmaceuticals Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 July 2012 and has a history of 12 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.70 M, as per Ministry of Corporate Affairs (MCA) records.
Palla Aparna, Shyamala Budda, Appala Shashikala, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2012PTC082077
- Company No.
082077
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2012
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Ipsum Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palla Aparna  | Director | 20-Jul-2012 | Current |
| Shyamala Budda | Director | 20-Jul-2012 | Current |
| Appala Shashikala | Director | 20-Jul-2012 | Current |
| Abhishek Budda | Director | 20-Jul-2012 | Current |
| Narender Kalakuntla | Director | 20-Jul-2012 | Current |
Financial Performance of Ipsum Pharmaceuticals.
Ipsum Pharmaceuticals Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 4.07% increase. The company also saw a slight improvement in profitability, with a 9.17% increase in profit. The company's net worth moved up by a moderate rise of 9.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ipsum Pharmaceuticals?
In 2017, Ipsum Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zovalta Pharmaceuticals Private Limited
Narender Kalakuntla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ipsum Pharmaceuticals?
Unlock and access historical data on people associated with Ipsum Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ipsum Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ipsum Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Ipsum Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Ipsum Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
- Balance Sheet
Ipsum Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
- Director Appointment
Palla Aparna was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 12 years 8 months .
- Director Appointment
Shyamala Budda was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 12 years 8 months .
- Director Appointment
Appala Shashikala was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 12 years 8 months .
- Director Appointment
Abhishek Budda was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 12 years 8 months .
Frequently asked questions
What is the Incorporation or founding date of Ipsum Pharmaceuticals Private Limited?
Ipsum Pharmaceuticals Private Limited was incorporated on 20 Jul 2012.
What is authorized share capital and paid-up capital of Ipsum Pharmaceuticals Private Limited?
The authorized share capital of Ipsum Pharmaceuticals Private Limited is ₹ 5.00 M and paid-up capital is ₹ 4.70 M.
Who are the current board members & directors of Ipsum Pharmaceuticals Private Limited?
Currently 5 directors are associated with Ipsum Pharmaceuticals Private Limited.
- Palla Aparna
- Shyamala Budda
- Appala Shashikala
- Abhishek Budda
- Narender Rao Kalakuntla
What is the registered address of Ipsum Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Ipsum Pharmaceuticals Private Limited is Plot No 101 102A Road 4 Raghavendra Nagar Bandlaguda, Nagole India, Hyderabad, Telangana, 500068.
What is the corporate identification number (CIN) and company number of Ipsum Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Ipsum Pharmaceuticals Private Limited is U24232TG2012PTC082077 and the company number is 082077 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Ipsum Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2017, the revenue trend for Ipsum Pharmaceuticals Private Limited has risen by 4.07%.
What change has been observed in the net worth of Ipsum Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2017 indicates that The net worth of Ipsum Pharmaceuticals Private Limited has experienced an upsurge of 9.88%.
When was the last Balance Sheet of Ipsum Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Ipsum Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2021.